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1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: We conducted a case series study to review the epidemiology
of human influenza A(H7N9) infection reported in Hong Kong.
Methods: We reviewed case records of confirmed human cases of influenza A(H7N9) infection
reported in Hong Kong in the 2013e2014 winter season. We compared the median viral shed-
ding duration and interval from illness onset to initiation of oseltamivir treatment between se-
vere and mild cases. We estimated the incubation period of influenza A(H7N9) virus from cases
with a single known date of poultry exposure.
Results: A total of 10 cases were reported and all were imported infection from Mainland
China. Four patients died and the cause of death was related to influenza A(H7N9) infection
in two patients. The median interval from illness onset to initiation of oseltamivir treatment
for the severe cases (4.5 days) was significantly longer than the mild cases (2 days;
p Z 0.025). Severe cases had a significantly longer viral shedding duration than mild cases
(p Z 0.028). The median incubation period for cases with a single known exposure date was
4 days. Nasopharyngeal aspirate taken from the 88 close contacts of the 10 patients all tested
negative for influenza A virus using reverse transcription polymerase chain reaction.
Conclusion: Delayed administration of antiviral treatment may be associated with a more se-
vere illness for influenza A(H7N9) infection. Despite our aggressive contact tracing policy with
laboratory testing of all close contacts, no secondary case was identified which implied that
the potential of human-to-human transmission of the circulating influenza A(H7N9) virus re-
mains low.
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Human influenza A(H7N9) infection was first reported in
China in March 2013.1 Since then, >450 laboratory
confirmed cases were reported to the World Health Orga-
nization.2 These cases were reported in different provinces
or municipalities in Mainland China, Taiwan, and
Malaysia.3e5
In Hong Kong, human influenza A(H7N9) infection is a
notifiable infectious disease under “Novel influenza A
infection”. Medical practitioners are required by law to
report suspected or confirmed cases to the Centre for
Health Protection (CHP) of the Department of Health.
Reporting criteria with clinical and epidemiological com-
ponents are in place (Table 1), and medical practitioners
are required to report suspected cases that fulfil both the
clinical and epidemiological criteria to the CHP for inves-
tigation. A confirmed case is defined as a patient with
clinically compatible illness with either positive viral cul-
ture or molecular testing for influenza A(H7N9) virus, or a
four-fold or higher rise in influenza A(H7N9) virus specific
antibody titer in paired serum samples.
The CHP conducted epidemiological investigations for all
reported cases. The patients and their attending doctors
were interviewed using a standardized questionnaire to
obtain clinical and exposure history. All reported cases
were admitted to public hospital for isolation, treatment,
and laboratory testing. Patients were placed under droplet,
contact, and airborne precautions until the diagnosis of
influenza A(H7N9) infection was refuted for suspected
cases, or until three consecutive respiratory specimens
tested negative for influenza A virus using reverse tran-
scription polymerase chain reaction (RT-PCR) for confirmed
cases.
We conducted contact tracing for all confirmed cases.
Contacts were categorized into “close contact” or “other
contact”. A close contact refers to a person who had close
(<1 m) unprotected contact with a case patient 1 day
before, through 14 days after symptom onset. This includes
healthcare workers who provided care for the patient
without adequate personal protective equipment. Other
contact refers to all other types of contacts who do not
fulfil the definition of close contact.Table 1 Reporting criteria for influenza A(H7N9) infection in H
Clinical criteria:
 a person with acute respiratory illness, characterized by fever
 a person with pneumonia; or
 a person who died of unexplained acute respiratory illness.
Epidemiological criteriadone or more of the following exposures
 contact with a human case of influenza A(H7N9); or
 contact with poultry or wild birds or their remains, or to envir
areas with documented avian influenza A(H7N9) infection in bi
 consumption of raw or undercooked poultry products in countr
infection in poultry and/or humans in the past 6 months a; or
 close contact with a confirmed influenza A(H7N9) infected anim
 worked in a laboratory that processes samples from persons or
 worked in the live poultry industry.
a The latest list of affected areas is regularly updated and is avai
Department of Health. Hong Kong.
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days after last exposure to the index patient. They were
quarantined either at an isolation room of the public hos-
pital or at a designated quarantine camp. Nasopharyngeal
aspirate was taken from each close contact including those
who were asymptomatic once quarantine commenced.
They were subject to an additional 10 days of medical
surveillance after the end of quarantine. For other con-
tacts, they were placed under medical surveillance for 20
days after last exposure to the index patient. All contacts
who developed fever or respiratory symptoms during the
quarantine or medical surveillance period were treated as a
suspected case of influenza A(H7N9) infection and were
immediately transferred to a public hospital for isolation
and laboratory testing.
The first case of human influenza A(H7N9) infection in
Hong Kong was confirmed on 2 December 2013.6 A total of
10 confirmed cases were reported in the winter season of
2013e2014. For the current winter season, three confirmed
cases were reported from December 2014 to February 2015.
We conducted a case series study to review the epidemi-
ology of the 10 confirmed cases of human influenza A(H7N9)
infection reported in the winter season of 2013e2014.
Methods
Data collection
We reviewed case records of the 10 confirmed cases of
human influenza A(H7N9) infection reported in the winter
season of 2013e2014. We retrieved information including
demographic characteristics (age, sex, and ethnicity), past
medical history, clinical presentation, details of antiviral
treatment, poultry exposure history, and serial RT-PCR re-
sults for influenza A of the patients from the case records.
Definitions
In this study, we defined severe cases as patients who had
developed respiratory failure or patients who died due to
influenza A(H7N9) infection. Other cases were regarded as
mild cases. Viral shedding duration was defined as theong Kong
(temperature >38oC) and cough and/or sore throat; or
in the 10 days prior to symptom onset:
onments contaminated by their feces in countries/
rds and/or humans in the past 6 months a; or
ies/areas with documented avian influenza A(H7N9)
al other than poultry or wild birds; or
animals that are suspected of avian influenza infection; or
lable on the website of the Centre for Health Protection of the
gy of human influenza A(H7N9) infection in Hong Kong, Journal of
1016/j.jmii.2015.06.004
Table 2 Demographic and clinical characteristics of the
10 confirmed cases of human influenza A(H7N9) infection in
Hong Kong, 2013e14 winter season
Characteristic No. of cases (%)








Shortness of breath 6 (60)
Runny nose 1 (10)
Sore throat 1 (10)
Coexisting medical condition
Diabetes mellitus 6 (60)
Hypertension 6 (60)
Coronary heart disease 4 (40)
Cerebrovascular disease 4 (40)
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of the last positive specimen from the patients. For cases
with a single known date of poultry exposure, we defined
the incubation period for each case as the interval between
the exposure date and the illness onset date.
Data analysis
We computed the median duration of viral shedding for all
10 patients. We compared the median viral shedding
duration as well as the median interval from illness onset to
initiation of oseltamivir treatment between severe and
mild cases. We estimated the incubation period of influenza
A(H7N9) virus by computing the median incubation period
for the cases with a single known exposure date. All data
were entered into a spreadsheet using Microsoft Excel
version 2010 (Microsoft Corporation, Redmond, Washing-
ton, United States). We used Mann-Whitney U test to
compare medians and Fisher’s exact test to compare pro-
portions. We used SPSS version 14.0 (SPSS Incorporated,
Delaware, United States) for all data analyses.
Results
From December 2013 to April 2014, >1800 suspected cases
of influenza A(H7N9) infection were reported to the CHP.
Among them, 10 cases were laboratory confirmed. Their
onset date ranged from 21 November 2013 to 11 April 2014
(Figure 1). Fifty percent of the patients were male. All were
Chinese except one patient who was Indonesian. The me-
dian age of the patients was 65 years (range: 5 months to 85
years). There were two pediatric patients aged 5 months
and 18 months, respectively. All adult patients reported
history of coexisting medical conditions. Diabetes mellitus,
hypertension, coronary heart disease, and cerebrovascular
disease were the most common conditions (Table 2).
Most patients presented with fever, cough, and short-
ness of breath. Sore throat or runny nose were uncommonly
reported (Table 2). The two pediatric patients presented
with a mild course of illness; one with upper respiratory
tract infection and the other with febrile convulsion. All
patients required hospitalization and the median intervalFigure 1. Onset date of the 10 confirmed cases of human
influenza A(H7N9) infection in Hong Kong, 2013e2014 winter
season.
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All adult patients had pneumonia and four of them
developed respiratory failure requiring mechanical ventila-
tion and intensive care. Among them, three patients
required treatment with extracorporeal membrane oxygen-
ation (ECMO). Antiviral treatment was not given to one pa-
tient as he died soon after admission. The others were all
treated with oseltamivir and three of them were also given
zanamavir. The median interval from illness onset to initia-
tion of oseltamivir treatment was 4 days (range: 0e8 days).
Overall, four patients died during hospital admission and
influenza A(H7N9) infection was the cause of death in two
cases. One case had developed respiratory failure requiring
intensive care treatment including mechanical ventilation
and ECMO therapy. Another case died approximately 10
hours following hospital admission without mechanical
ventilation or intensive care. The interval from illness onset
to death in these two cases was 10 days and 3 days, respec-
tively. For the other two fatal cases, clearance of the virus
was shown using RT-PCR in three sets of respiratory speci-
mens taken weeks before their death. Their cause of death
was aspiration pneumonia and ventilator-associated pneu-
monia, respectively. The interval from illness onset to death
in these two cases was 20 days and 62 days, respectively.
Seven patients were diagnosed by detection of influenza
A(H7N9) virus using RT-PCR in upper respiratory tract
specimens (nasopharyngeal aspirate for 4 patients and
nasopharyngeal swab for 3 patients). The remaining three
patients had positive sputum specimens, while two of them
had negative concurrent nasopharyngeal aspirate. Viral
shedding duration ranged from 0 day to 23 days with a
median of 3.5 days. In one fatal case, influenza A(H7N9)
virus was detected in postmortem lung, trachea, and heart
tissues using RT-PCR, while liver tissue was negative.
The four patients with respiratory failure requiring me-
chanical ventilation and the patient who died soon after
admission were regarded as severe cases. The mediangy of human influenza A(H7N9) infection in Hong Kong, Journal of
1016/j.jmii.2015.06.004
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treatment for the severe cases (4.5 days) was significantly
longer than the mild cases (2 days; p Z 0.025). Severe
cases also had a significantly longer viral shedding duration
(median: 10 days, range: 2e23 days) than the mild cases
(median: 1 day, range: 0e4 days; p Z 0.028).
Our epidemiological investigations revealed that all pa-
tients contracted the infection from different cities of the
Guangdong Province of China: six cases in Shenzhen and
one case each in Kaiping, Shunde, Guangzhou, and Dong-
guan. Only two patients reported history of direct contact
with poultry. They had been involved in slaughtering live
chickens. Seven cases (including the 2 cases who reported
history of direct contact) had history of visits to markets
with live poultry stalls (Table 3). In two cases, family
members of the patient had visited markets with live
poultry stalls. For the remaining case, the patient only
recalled history of having walked past the entrance of a
market with live poultry stalls. Four patients had a single
known exposure date and the median incubation period was
4 days (range: 1e7 days).
Contact tracing identified 88 close contacts for the 10
patients. The number of close contacts identified for each
patient ranged from 0 to 19 (median: 8). These close con-
tacts included 44 family members, 42 hospital contacts, a
travel collateral of a patient, and a taxi driver who drove a
patient to hospital. Nasopharyngeal aspirate taken from all
close contacts when quarantine commenced tested nega-
tive for influenza A virus using RT-PCR. Six of these had
developed fever and/or respiratory symptoms during the
quarantine or medical surveillance period and repeated
nasopharyngeal aspirates all tested negative for influenza A
virus using RT-PCR.
We also identified a total of 924 other contacts for the 10
cases studied. The number of other contacts identified for
each patient ranged from 43 to 230 (median: 80). Seventy-
six of these had developed fever and/or respiratory symp-
toms during the medical surveillance period and nasopha-
ryngeal aspirate taken from them all tested negative for
influenza A virus using RT-PCR.
Discussion
In this report, we described the public health management
of human influenza A(H7N9) infection in Hong Kong and
reviewed the epidemiology of the 10 confirmed casesTable 3 Exposure history of the 10 confirmed cases of
human influenza A(H7N9) infection in Hong Kong, 2013e14
winter season
Exposure No. of cases (%)a
Visited market with live poultry stalls 7 (70)
Slaughtered live chickens 2 (20)
Family member had visited market
with live poultry stalls
2 (20)
Walked past the entrance of market
with live poultry stalls
1 (10)
a One patient can have more than one type of exposure.
Please cite this article in press as: Leung Yiu-hong, et al., Epidemiolo
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.reported in the 2013e2014 winter season. Compared with
the case series reported by Gao et al7, the percentage of
patients aged  65 years (70% vs 42%), with diabetes mel-
litus (60% vs 16%), or with coronary heart disease (40% vs
10%) was higher among our patients. By contrast, the per-
centage of patients that required mechanical ventilation
among our cases was much lower (40% vs 86%), while the
median interval from illness onset to initiation of antiviral
treatment was shorter in our series (4 days vs. 7 days). It is
possible that delayed antiviral treatment is associated with
the development of more severe illness. Our study has also
demonstrated that severe cases have a significantly longer
median interval from illness onset to initiation of oselta-
mivir treatment than mild cases. As such, earlier adminis-
tration of antiviral treatment may account for the lower
complication rate among our cases compared with the
study by Gao et al.7
In one of our cases who was complicated with respira-
tory and renal failure, influenza RNA was detected in res-
piratory specimens for up to 23 days after illness onset. To
the best of our knowledge, it is probably the longest viral
shedding duration reported for influenza A(H7N9)
infection.5,7e11 We also found that severe cases are asso-
ciated with a significantly longer viral shedding duration.
Similar viral shedding kinetics were observed for influenza
A(H1N1)pdm09 infection. A recent systematic review has
found that the mean duration of viral shedding generally
increased with severity of clinical presentation.12 Unfor-
tunately, our study had a small sample size and, therefore,
the finding should be interpreted with caution.
In one of the fatal cases in our study, influenza A(H7N9)
RNA was detected in postmortem lung, trachea, and heart
tissues using RT-PCR. The patient had a history of aortic
dissection with aortic valve replacement. Findings of
postmortem examination reported by local researchers
revealed the presence of a thrombus over the prosthetic
valve in which influenza viral antigen was detected by
immunohistochemistry in isolated monocytic cells within
the thrombus.13 The presence of viral RNA in multiple or-
gans was suggestive of a disseminated infection.
Visits to markets with live poultry stalls has been iden-
tified as a risk factor for influenza A(H7N9) infection.14,15 In
our series, 70% of cases reported history of visits to markets
with live poultry stalls, which is similar to figures in other
published reports which ranged from approximately 50% to
75%.3,14e17 Unfortunately, the exact mode of transmission,
whether by inhalation of contaminated droplets/aerosol or
by fomite transmission, in these patients remains obscure.
Further research in this aspect is urgently needed in order
to formulate appropriate prevention strategies.
The median incubation period of influenza A(H7N9)
infection for cases with a single known exposure reported in
the literature ranged from 6 days to 7 days.3,18e19 In our
study, the median incubation period estimated from cases
with a single known exposure was 4 days which was shorter
than the figures reported in the case series mentioned
above. However, our results are similar to the study findings
of Cowling et al16 who estimated the mean incubation
period of influenza A(H7N9) virus to be 3.1 days using
modelling methods.
Our epidemiological investigation identified >80 close
contacts for the 10 patients. One half of these were familygy of human influenza A(H7N9) infection in Hong Kong, Journal of
1016/j.jmii.2015.06.004
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face-to-face interaction with the cases. Nevertheless,
nasopharyngeal aspirate taken from all these contacts
tested negative for the virus. Those who had developed
respiratory symptoms during the quarantine or medical
surveillance period also had their nasopharyngeal aspirate
tested negative for the virus. This fact adds another piece
of evidence supporting the low potential of human-to-
human transmission of the circulating influenza A(H7N9)
virus.
In Hong Kong, we adopted an aggressive public health
approach to the prevention and control of influenza
A(H7N9) infection. Medical practitioners are required to
report all patients that fulfil the reporting criteria to the
CHP for epidemiological investigation, and laboratory
diagnosis is performed for all these cases. We also con-
ducted exhaustive contact tracing with quarantine of close
contacts for each confirmed case. Currently, the virus has
not yet been able to spread efficiently between humans
and we are still able to cope with the resources required for
this approach. However, should the virus transmission be-
tween humans become efficient and community-wide
transmission established, laboratory diagnosis and epide-
miological investigation of each suspected case would
become impossible. At that juncture, resources should be
focused on mitigation of impact of the outbreak to the
community. Instead of identifying and investigation of all
cases, empirical antiviral treatment for a defined target
group with presumptive diagnosis of the infection should be
considered, taking into account of the transmissibility and
virulence of the virus as well as the availability of antiviral
agents.
In conclusion, we reviewed the epidemiology of the 10
confirmed cases of human influenza A(H7N9) infection in
Hong Kong reported in the 2013e2014 winter season. All
cases were imported infection from Mainland China. We
conducted aggressive contact tracing and quarantine
measures to prevent secondary spread of the disease in
Hong Kong. Our study findings suggested that delayed
administration of antiviral treatment may be associated
with a more severe illness for influenza A(H7N9) infection.
In addition, despite our aggressive contact tracing policy
with laboratory testing of all close contacts, the absence of
secondary cases implied that the human-to-human trans-
mission potential of the circulating influenza A(H7N9) virus
remains low. However, on-going epidemiological surveil-
lance is of utmost importance to detect changes in the
human-to-human transmission potential of the virus such
that appropriate public health control measures could be
instituted in a timely manner.Conflicts of interest
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